184 related articles for article (PubMed ID: 22449247)
41. Current status of vitamin D signaling and its therapeutic applications.
Carlberg C; Molnar F
Curr Top Med Chem; 2012; 12(6):528-47. PubMed ID: 22242854
[TBL] [Abstract][Full Text] [Related]
42. Noncalcemic actions of vitamin D receptor ligands.
Nagpal S; Na S; Rathnachalam R
Endocr Rev; 2005 Aug; 26(5):662-87. PubMed ID: 15798098
[TBL] [Abstract][Full Text] [Related]
43. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, and biological activity of D-bishomo-1α,25-dihydroxyvitamin D
Fabisiak A; Brzeminski P; Sicinski RR; Rochel N; Maj E; Filip-Psurska B; Wietrzyk J; Plum LA; DeLuca HF
Eur J Med Chem; 2024 May; 271():116403. PubMed ID: 38615411
[TBL] [Abstract][Full Text] [Related]
45. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.
Kaya T; Swamy N; Persons KS; Ray S; Mohr SC; Ray R
Bioorg Chem; 2009 Apr; 37(2):57-63. PubMed ID: 19223058
[TBL] [Abstract][Full Text] [Related]
46. Crystal structure of hereditary vitamin D-resistant rickets--associated mutant H305Q of vitamin D nuclear receptor bound to its natural ligand.
Rochel N; Hourai S; Moras D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):84-7. PubMed ID: 20403435
[TBL] [Abstract][Full Text] [Related]
47. [Structural refinement of seco-steroidal skeleton and the biological activity through nuclear receptors].
Kittaka A
Yakugaku Zasshi; 2008 Sep; 128(9):1235-50. PubMed ID: 18758137
[TBL] [Abstract][Full Text] [Related]
48. Vitamin D receptor as a drug discovery target.
Pinette KV; Yee YK; Amegadzie BY; Nagpal S
Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
[TBL] [Abstract][Full Text] [Related]
49. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.
Carlberg C; Molnár F
Curr Top Med Chem; 2006; 6(12):1243-53. PubMed ID: 16848738
[TBL] [Abstract][Full Text] [Related]
50. Antagonistic action of a 25-carboxylic ester analogue of 1alpha, 25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators.
Herdick M; Steinmeyer A; Carlberg C
J Biol Chem; 2000 Jun; 275(22):16506-12. PubMed ID: 10748178
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1alpha,25-(OH)2D3.
Plonska-Ocypa K; Grzywacz P; Sicinski RR; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):298-304. PubMed ID: 17223343
[TBL] [Abstract][Full Text] [Related]
52. Characterization of vitamin D receptor ligands with cell-specific and dissociated activity.
Castillo AI; Sánchez-Martínez R; Jiménez-Lara AM; Steinmeyer A; Zügel U; Aranda A
Mol Endocrinol; 2006 Dec; 20(12):3093-104. PubMed ID: 16901972
[TBL] [Abstract][Full Text] [Related]
53. Ligand binding domain of vitamin D receptors.
Rochel N; Moras D
Curr Top Med Chem; 2006; 6(12):1229-41. PubMed ID: 16848737
[TBL] [Abstract][Full Text] [Related]
54. Ligand-dependent conformation change reflects steric structure and interactions of a vitamin D receptor/ligand complex: a fragment molecular orbital study.
Motoyoshi S; Yamagishi K; Yamada S; Tokiwa H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):56-9. PubMed ID: 20236615
[TBL] [Abstract][Full Text] [Related]
55. Ligand recognition by the vitamin D receptor.
Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
[TBL] [Abstract][Full Text] [Related]
56. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.
Rochel N; Wurtz JM; Mitschler A; Klaholz B; Moras D
Mol Cell; 2000 Jan; 5(1):173-9. PubMed ID: 10678179
[TBL] [Abstract][Full Text] [Related]
57. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
Ciesielski F; Rochel N; Moras D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
[TBL] [Abstract][Full Text] [Related]
58. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):243-62. PubMed ID: 17368177
[TBL] [Abstract][Full Text] [Related]
59. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
[TBL] [Abstract][Full Text] [Related]
60. Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives.
Masuno H; Ikura T; Morizono D; Orita I; Yamada S; Shimizu M; Ito N
J Lipid Res; 2013 Aug; 54(8):2206-2213. PubMed ID: 23723390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
